IGIBvsXPH
iShares 5-10 Year Investment Grade Corporate Bond ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGIB | XPH | |
|---|---|---|
| Expense ratio | 0.040% | 0.35% |
| Assets | $19.5B | $440M |
| Net flow, 1 month | +$845M | −$80M |
| Net flow, 1 year | +$3.9B | +$206M |
| Return, YTD | -5.2% | +14.2% |
| Return, 1 year | -6.3% | +30.2% |
| Avg daily volume | 4.3M | 198K |
| Holdings | 2744 | 41 |
| Listed | Jan 5, 2007 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS